ORPHA:85287
X-linked intellectual disability, Siderius type
Publications
1,490
Trials
0
Interventional, condition-specific
Researchers
267
Distinct authors in sample
Gene link
PHF8
Definitive
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
X-linked , Siderius type is characterised by mild to borderline intellectual deficit associated with cleft lip/palate. Preaxial polydactyly, large hands and cryptorchidism are sometimes present. The syndrome has been described in seven boys from two families. Transmission is X-linked and the syndrome is caused by mutations in the PHF8 gene, localised to the p11.21 region of the X chromosome.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010286
- MeSH:C537333
- OMIM:300263
- UMLS:C1846055
Additional Mondo synonyms (7)
MRXSSD · Siderius X-linked intellectual disability syndrome · Siderius X-linked mental retardation syndrome · Siderius-Hamel syndrome · intellectual developmental disorder, X-linked, syndromic, Siderius type, X-linked recessive · intellectual disability syndrome, X-linked, Siderius type · syndromic X-linked intellectual disability Siderius type
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No matched interventional trial, but a gene association and an animal model are on record — often described as translation-ready / stalled at the clinical step.
- Gene identifiedPresent
Definitive — PHF8
- LiteraturePresent
1,490 matched papers (1,084 in last 10 years) Source
- Phenotype characterisedPresent
31 HPO annotations (e.g. Upslanted palpebral fissure; Sloping forehead; Large hands) Source
- Animal modelPresent
1 genotype model (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (PHF8).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
31
Associated phenotypes · MONDO:0010286
- Upslanted palpebral fissure
- Sloping forehead
- Large hands
- Cleft palate
- Microcephaly
Showing 5 of 31 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- Phf8tm1.1Cdcn/Y [background:] B6.129S6(Cg)-Phf8tm1.1Cdcn·MGI:6370003·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,490
1,490 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,490 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,084 in the last 10 years · low confidence
Phrase hits: 41 · MeSH hits: 1
Who's working on it?
267
Distinct author names in 41 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Martínez-Balbás MA3 papers · 2026
Department of Molecular Genomics, Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.
Papers in Europe PMC - 02van Bokhoven H3 papers · 2022
Department of Human Genetics, Donders Institute for Brain, Behaviour and Cognition, Radboudumc, Nijmegen, The Netherlands.
Papers in Europe PMC - 03Asensio-Juan E2 papers · 2017
Department of Molecular Genomics, Instituto de Biología Molecular de Barcelona, Spanish Research Council (CSIC), Barcelona Science Park, Barcelona 08028, Spain.
Papers in Europe PMC - 04de la Cruz X2 papers · 2026
Vall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119, E-08035 Barcelona, Spain.
Papers in Europe PMC - 05Fortschegger K2 papers · 2011
Center for Genomic Regulation, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.
Papers in Europe PMC - 06Gallego C2 papers · 2017
Department of Cell Biology, Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.
Papers in Europe PMC - 07Iacobucci S2 papers · 2026
Department of Molecular Genomics, Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona 08028, Spain.
Papers in Europe PMC - 08Kalscheuer VM2 papers · 2022
Max Planck Institute for Molecular Genetics, Research Group Development and Disease, Ihnestr. 63-73, 14195 Berlin, Germany.
Papers in Europe PMC - 09Kremp M2 papers · 2026
Institut für Biochemie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Papers in Europe PMC - 10Lee JH2 papers · 2017
Department of Biological Sciences, Konkuk University, Seoul 05029, Korea. kingmega@konkuk.ac.kr.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for X-linked intellectual disability, Siderius type — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("X-linked intellectual disability, Siderius type" OR "MRXSSD" OR "Siderius X-linked intellectual disability syndrome" OR "Siderius X-linked mental retardation syndrome" OR "Siderius-Hamel syndrome" OR "intellectual developmental disorder, X-linked, syndromic, Siderius type, X-linked recessive" OR "intellectual disability syndrome, X-linked, Siderius type" OR "syndromic X-linked intellectual disability Siderius type") OR (MESH:"Siderius X-linked mental retardation syndrome") OR ("PHF8" OR "PHF8 syndrome" OR "PHF8-related")MeSH descriptor terms unioned into the query: Siderius X-linked mental retardation syndrome
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"X-linked intellectual disability, Siderius type" OR "MRXSSD" OR "Siderius X-linked intellectual disability syndrome" OR "Siderius X-linked mental retardation syndrome" OR "Siderius-Hamel syndrome" OR "intellectual developmental disorder, X-linked, syndromic, Siderius type, X-linked recessive" OR "intellectual disability syndrome, X-linked, Siderius type" OR "syndromic X-linked intellectual disability Siderius type"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1490) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T02:52:56.135Z
